Amanote Research

Amanote Research

    RegisterSign In

Role of Trabectedin in the Treatment of Soft Tissue Sarcoma

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s4454
Full Text
Open PDF
Abstract

Available in full text

Categories
OncologyPharmacology
Date

May 1, 2009

Authors
Serge Leyvraz
Publisher

Informa UK Limited


Related search

Trabectedin in the Treatment of Patients With Soft Tissue Sarcoma

Nowotwory
Cancer ResearchOncology
2018English

The Value of Trabectedin in the Treatment of Soft Tissue Sarcoma

Therapeutics and Clinical Risk Management
2016English

BRCA1 Haplotype and Clinical Benefit of Trabectedin in Soft-Tissue Sarcoma Patients

British Journal of Cancer
Cancer ResearchOncology
2015English

Efficacy of Trabectedin in Advanced Soft Tissue Sarcoma: Beyond Lipo- And Leiomyosarcoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Trabectedin Plus Olaparib Has Activity in Patients With Soft-Tissue Sarcoma

Cancer Discovery
Oncology
2018English

Role of Molecular Profiling in Soft Tissue Sarcoma

Journal of the National Comprehensive Cancer Network : JNCCN
MedicineOncology
2018English

The Role of Pulmonary Metastasectomy for Soft Tissue Sarcoma

Acta Orthopaedica Scandinavica
1997English

Trabectedin for Inoperable or Recurrent Soft Tissue Sarcoma in Adult Patients: A Retrospective Cohort Study

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Treatment of Pelvic Bone and Soft Tissue Sarcoma.

Orthopedics & Traumatology
1997English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy